Skip to main content
TanyaKanker
Foshan Fosun Chancheng Hospital building

Golden Provider · Foshan, China

Foshan Fosun Chancheng Hospital

Coordinated access for CyberKnife M6 / SRS-SBRT review, with facility identity, clinician, process, and verification limits clearly shown.

Upload reports for reviewView the access pathway

Identity

Confirmed

Name, location, and hospital are verified from the official website.

Capability

Documented

CyberKnife M6 is listed as a hospital service.

International access

Active route

FIMC and the Indonesia office provide an international-patient coordination route.

Patient suitability

Review required

This is not a clinical fit result; a doctor must review the records.

Cost

Quote required

No verified public package tariff is available.

Featured capability

CyberKnife M6 / SRS-SBRT

Precision stereotactic radiotherapy for selected indications. Suitability cannot be decided from diagnosis name alone and always requires clinical team review.

  • Selected brain metastases and intracranial tumors
  • Selected lung cancers or lung metastases
  • Selected liver tumors or metastases
  • Selected pancreatic, prostate, and bone metastasis cases

This list shows the scope published by the provider, not a recommendation or a patient suitability result.

Dr. Wang Enmin

Lead doctor

Dr. Wang Enmin

Chief Radiation Oncologist, Precision Tumor Diagnosis and Treatment Center

View doctor profile

Documented focus

Gamma KnifeCyberKnifeNeuro-radiosurgerySRS/SBRT

Affiliation and focus come from the provider's official profile. Schedule and case acceptance must be confirmed after review.

Fosun Health public footprint

A wider network behind the hospital

These figures and operating facts are published by Fosun Health. They describe the provider network and are not TanyaKanker outcomes, patient volume or a partnership claim.

FIMC

20,000 m² · 100 planned beds

Foshan's international medical center opened on 28 March 2026 with a dual-physician model combining generalists and specialists.

Provider source

International reach

>50,000 patients from >130 countries

Published by Fosun Health for its four Greater Bay Area hospitals; this is not TanyaKanker's patient volume.

Provider source

Oncology collaboration

200+ experts · 15 countries

The 2026 Foshan International Oncology Treatment Forum established a Global Oncology Collaboration Alliance for cross-border case discussion and second opinions.

Provider source

Indonesia route

Jakarta office · Bahasa Indonesia channel

The official Fosun Health site lists an Indonesia office and Indonesian-language channel. This is not a TanyaKanker partnership claim.

Provider source

Provider-published case narratives

Three cases, read with their limits

Fosun selected and published these narratives. They are not a controlled series, risk-adjusted benchmark or evidence that the same approach fits another patient. The source of every case is linked below.

2025-11-04

Non-small cell lung cancer · stage IA

CyberKnife in early-stage NSCLC

The hospital narrative describes a 72-year-old woman with stage IA NSCLC receiving CyberKnife 54 Gy in three fractions. The source reports no active lesion on PET-CT after 11 months and no adverse complications reported.

One selected provider-published case. It does not establish an average result, success rate, or outcome guarantee for another patient.

Read the provider's published case
2026-07-15

Pulmonary nodule · robotic minimally invasive surgery

Da Vinci lung lobectomy for a Vietnamese patient

The hospital narrative describes a Vietnamese patient undergoing right lower lobectomy with Da Vinci. It reports light activity on postoperative day two, drain removal on day four, and discharge within the visa period.

A single provider narrative, not a controlled study or evidence that this approach is suitable for every lung nodule.

Read the provider's published case
2026-07-27

Tuberous sclerosis complex · renal angiomyolipoma

Robotic kidney-sparing surgery for a TSC-related tumour

The hospital narrative describes a 20-year-old patient with TSC and a renal tumour larger than 7 cm undergoing robot-assisted partial surgery to remove two tumours while preserving the left kidney.

A selected provider case. Complexity, risk, and individual outcomes cannot be extrapolated to another patient.

Read the provider's published case
Use the hospital-selection checklist before acting on a case story

From reports to access

One pathway you can follow

TanyaKanker helps coordinate and organise documents. Clinical decisions, acceptance, schedules, and quotes remain with the hospital.

  1. 1

    Upload medical history and records privately

  2. 2

    TanyaKanker prepares a PatientCase and checks completeness

  3. 3

    The access team sends a summary for specialist review

  4. 4

    The hospital confirms options, document needs, and cost estimate

  5. 5

    If the patient chooses to continue, the team helps with appointment, visa, and travel

Documents for initial review

  • Pathology / histopathology report
  • Most recent CT, MRI, or PET-CT; include DICOM if available
  • Treatment summary and prior radiotherapy dates
  • Recent laboratory results
  • Biomarker / NGS results if relevant
  • Discharge summary or referral letter

Initial list; the hospital may request additional documents after reading the case.

Cost context

PROVIDER QUOTE REQUIRED

A cost estimate can be prepared only after the team reviews diagnosis, target location, imaging, prior radiotherapy history, and fractionation plan. TanyaKanker does not display a number before a written provider quote exists.

Next step

Start with the reports you already have

A case is not accepted automatically. The team checks completeness before requesting provider review.

Start PatientCase

Last reviewed by TanyaKanker: 2026-09-12

No guarantee of outcome, schedule, acceptance, or cost.

Prepare for your next consultation

Use the free six-question tool to prepare questions for your doctor.

Start free · 6 questionsContact a navigatorSaved pages